CLRB - CIK 0001279704
Cellectar Biosciences, Inc. has filed 1,001 documents with the SEC between 2011 and 2026. The most frequent type is major company event (367 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-05-13 | 2025-05-13 |
| Major company event | 8-K | 2025-05-01 | 2025-04-30 |
| Proxy materials | DEFA14A | 2025-04-28 | - |
| Annual report to shareholders | ARS | 2025-04-28 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-28 | 2025-06-13 |
| PRE 14A | - | 2025-04-18 | 2025-04-18 |
| Major company event | 8-K | 2025-03-17 | 2025-03-11 |
| Annual report | 10-K | 2025-03-13 | 2024-12-31 |
| Major company event | 8-K | 2025-03-13 | 2025-03-13 |
| Insider trade | 4 | 2025-03-12 | 2025-01-10 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| Insider trade | 4 | 2025-02-18 | 2025-02-14 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-13 | - |
| 424B3 | - | 2025-02-07 | - |
| EFFECT | - | 2025-02-06 | - |
| Company correspondence | CORRESP | 2025-02-04 | - |
| SCHEDULE 13G/A | - | 2025-02-03 | - |
| SEC correspondence | UPLOAD | 2025-02-03 | - |
| Major company event | 8-K | 2025-01-31 | 2025-01-30 |
| IPO registration | S-1 | 2025-01-29 | - |
| SCHEDULE 13G/A | - | 2025-01-27 | - |
| Major company event | 8-K | 2025-01-14 | 2025-01-12 |
| Major company event | 8-K | 2024-12-11 | 2024-12-10 |
| Quarterly report | 10-Q | 2024-11-18 | 2024-09-30 |
| Major company event | 8-K | 2024-11-18 | 2024-11-18 |
| Major company event | 8-K | 2024-11-15 | 2024-11-15 |
| SCHEDULE 13G/A | - | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| NT 10-Q | - | 2024-11-13 | 2024-09-30 |
| Major company event | 8-K | 2024-11-01 | 2024-11-01 |
| Quarterly report | 10-Q | 2024-10-29 | 2024-06-30 |
| Quarterly report (amended) | 10-Q/A | 2024-10-29 | 2024-03-31 |
| Annual report (amended) | 10-K/A | 2024-10-29 | 2023-12-31 |
| Major company event | 8-K | 2024-08-23 | 2024-08-20 |
| Passive ownership stake (update) | SC 13G/A | 2024-08-14 | - |
| NT 10-Q | - | 2024-08-14 | 2024-06-30 |
| Major company event | 8-K | 2024-08-13 | 2024-08-13 |
| Major company event | 8-K | 2024-08-09 | 2024-08-09 |
| EFFECT | - | 2024-07-23 | - |
| Major company event | 8-K | 2024-07-23 | 2024-07-23 |
| Company correspondence | CORRESP | 2024-07-22 | - |
| Major company event | 8-K | 2024-07-22 | 2024-07-21 |